These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3493299)
1. A novel MHC class I molecule as a tumour-specific antigen. Correlation between the antibody-defined and the CTL-defined target structure. Philipps C; Stauss HJ; Wortzel RD; Schreiber H J Immunogenet; 1986; 13(2-3):93-9. PubMed ID: 3493299 [TBL] [Abstract][Full Text] [Related]
2. Immunological characterization of tumor-rejection antigens on ultraviolet-light-induced tumors originating in the CB6F1 mouse. Kitajima T; Iwashiro M; Kuribayashi K; Imamura S Cancer Immunol Immunother; 1994 Jun; 38(6):372-8. PubMed ID: 8205558 [TBL] [Abstract][Full Text] [Related]
3. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response. Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798 [TBL] [Abstract][Full Text] [Related]
4. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens. Schirrmacher V; Schild HJ; Gückel B; von Hoegen P Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150 [TBL] [Abstract][Full Text] [Related]
5. Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transfer. Stauss HJ; Van Waes C; Fink MA; Starr B; Schreiber H J Exp Med; 1986 Nov; 164(5):1516-30. PubMed ID: 3490532 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses. Roberts LK J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813 [TBL] [Abstract][Full Text] [Related]
7. Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination. Kuribayashi K; Tanaka C; Matsubayashi Y; Masuda T; Udono H; Abe M; Nakayama E; Shiku H J Immunol; 1988 Dec; 141(11):4074-80. PubMed ID: 2460558 [TBL] [Abstract][Full Text] [Related]
8. Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro. Van Waes C; Monach PA; Urban JL; Wortzel RD; Schreiber H Tissue Antigens; 1996 May; 47(5):399-407. PubMed ID: 8795140 [TBL] [Abstract][Full Text] [Related]
9. Class II antigen-specific murine cytolytic T lymphocytes (CTL). II. Genuine class II specificity of Lyt-2+ CTL clones. Shinohara N; Hozumi N; Watanabe M; Bluestone JA; Johnson-Leva R; Sachs DH J Immunol; 1988 Jan; 140(1):30-6. PubMed ID: 3257229 [TBL] [Abstract][Full Text] [Related]
10. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function. Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156 [TBL] [Abstract][Full Text] [Related]
11. Dissection of tumour-specific antigenicity. Wortzel RD; Stauss HJ; Van Waes C; Schreiber H Cancer Surv; 1985; 4(1):115-34. PubMed ID: 3879854 [TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance. Ward PL; Koeppen HK; Hurteau T; Rowley DA; Schreiber H Cancer Res; 1990 Jul; 50(13):3851-8. PubMed ID: 2112981 [TBL] [Abstract][Full Text] [Related]
13. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection. Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338 [TBL] [Abstract][Full Text] [Related]
14. Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones. Wortzel RD; Urban JL; Philipps C; Fitch FW; Schreiber H J Immunol; 1983 May; 130(5):2461-6. PubMed ID: 6187859 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T cell clones against human autologous cancers: analysis of target antigen and the mechanism of specific target cell destruction. Kikuchi K; Okubo M; Sato T; Sato N Princess Takamatsu Symp; 1988; 19():303-13. PubMed ID: 3269362 [TBL] [Abstract][Full Text] [Related]
16. Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes. Kranz DM; Tonegawa S; Eisen HN Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7922-6. PubMed ID: 6334855 [TBL] [Abstract][Full Text] [Related]
17. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells. Chen PW; Kaba DS; Ananthaswamy HN Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370 [TBL] [Abstract][Full Text] [Related]
18. Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. Ward PL; Koeppen H; Hurteau T; Schreiber H J Exp Med; 1989 Jul; 170(1):217-32. PubMed ID: 2787379 [TBL] [Abstract][Full Text] [Related]
19. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens. Dudley ME; Roopenian DC J Exp Med; 1996 Aug; 184(2):441-7. PubMed ID: 8760797 [TBL] [Abstract][Full Text] [Related]
20. The role of T8 in the cytotoxic activity of cloned cytotoxic T lymphocyte lines specific for class II and class I major histocompatibility complex antigens. Spits H; Yssel H; Voordouw A; de Vries JE J Immunol; 1985 Apr; 134(4):2294-8. PubMed ID: 2579137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]